"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","relation"
"GSM527858","Prostate tumor PCA0001 transcript","GSM527858","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0001","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527858/GSM527858_YX_Exon1_PCA0001.CEL.gz","43419","Alternative to: GSM526134 (gene-level analysis)"
"GSM527859","Prostate tumor PCA0002 transcript","GSM527859","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0002","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527859/GSM527859_YX_Exon1_PCA0002.CEL.gz","43419","Alternative to: GSM526135 (gene-level analysis)"
"GSM527860","Prostate tumor PCA0003 transcript","GSM527860","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0003","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527860/GSM527860_YX_Exon1_PCA0003.CEL.gz","43419","Alternative to: GSM526136 (gene-level analysis)"
"GSM527861","Prostate tumor PCA0005 transcript","GSM527861","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0005","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527861/GSM527861_YX_Exon1_PCA0005.CEL.gz","43419","Alternative to: GSM526137 (gene-level analysis)"
"GSM527862","Prostate tumor PCA0007 transcript","GSM527862","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0007","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527862/GSM527862_YX_Exon1_PCA0007.CEL.gz","43419","Alternative to: GSM526138 (gene-level analysis)"
"GSM527863","Prostate tumor PCA0008 transcript","GSM527863","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0008","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527863/GSM527863_YX_Exon1_PCA0008.CEL.gz","43419","Alternative to: GSM526139 (gene-level analysis)"
"GSM527864","Prostate tumor PCA0009 transcript","GSM527864","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0009","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527864/GSM527864_YX_Exon1_PCA0009.CEL.gz","43419","Alternative to: GSM526140 (gene-level analysis)"
"GSM527865","Prostate tumor PCA0010 transcript","GSM527865","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0010","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527865/GSM527865_YX_Exon1_PCA0010.CEL.gz","43419","Alternative to: GSM526141 (gene-level analysis)"
"GSM527866","Prostate tumor PCA0011 transcript","GSM527866","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0011","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527866/GSM527866_YX_Exon1_PCA0011.CEL.gz","43419","Alternative to: GSM526142 (gene-level analysis)"
"GSM527867","Prostate tumor PCA0012 transcript","GSM527867","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0012","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527867/GSM527867_YX_Exon1_PCA0012.CEL.gz","43419","Alternative to: GSM526143 (gene-level analysis)"
"GSM527868","Prostate tumor PCA0013 transcript","GSM527868","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0013","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527868/GSM527868_YX_Exon1_PCA0013.CEL.gz","43419","Alternative to: GSM526144 (gene-level analysis)"
"GSM527869","Prostate tumor PCA0014 transcript","GSM527869","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0014","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527869/GSM527869_YX_Exon1_PCA0014.CEL.gz","43419","Alternative to: GSM526145 (gene-level analysis)"
"GSM527870","Prostate tumor PCA0015 transcript","GSM527870","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0015","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527870/GSM527870_YX_Exon1_PCA0015.CEL.gz","43419","Alternative to: GSM526146 (gene-level analysis)"
"GSM527871","Prostate tumor PCA0017 transcript","GSM527871","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0017","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527871/GSM527871_YX_Exon1_PCA0017.CEL.gz","43419","Alternative to: GSM526147 (gene-level analysis)"
"GSM527872","Prostate tumor PCA0018 transcript","GSM527872","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0018","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527872/GSM527872_YX_Exon1_PCA0018.CEL.gz","43419","Alternative to: GSM526148 (gene-level analysis)"
"GSM527873","Prostate tumor PCA0020 transcript","GSM527873","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0020","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527873/GSM527873_YX_Exon1_PCA0020.CEL.gz","43419","Alternative to: GSM526149 (gene-level analysis)"
"GSM527874","Prostate tumor PCA0021 transcript","GSM527874","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0021","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527874/GSM527874_YX_Exon1_PCA0021.CEL.gz","43419","Alternative to: GSM526150 (gene-level analysis)"
"GSM527875","Prostate tumor PCA0022 transcript","GSM527875","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0022","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527875/GSM527875_YX_Exon1_PCA0022.CEL.gz","43419","Alternative to: GSM526151 (gene-level analysis)"
"GSM527876","Prostate tumor PCA0024 transcript","GSM527876","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0024","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527876/GSM527876_YX_Exon1_PCA0024.CEL.gz","43419","Alternative to: GSM526152 (gene-level analysis)"
"GSM527877","Prostate tumor PCA0025 transcript","GSM527877","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0025","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527877/GSM527877_YX_Exon1_PCA0025.CEL.gz","43419","Alternative to: GSM526153 (gene-level analysis)"
"GSM527878","Prostate tumor PCA0026 transcript","GSM527878","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0026","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527878/GSM527878_YX_Exon1_PCA0026.CEL.gz","43419","Alternative to: GSM526154 (gene-level analysis)"
"GSM527879","Prostate tumor PCA0027 transcript","GSM527879","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0027","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 5","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527879/GSM527879_YX_Exon1_PCA0027.CEL.gz","43419","Alternative to: GSM526155 (gene-level analysis)"
"GSM527880","Prostate tumor PCA0028 transcript","GSM527880","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0028","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527880/GSM527880_YX_Exon1_PCA0028.CEL.gz","43419","Alternative to: GSM526156 (gene-level analysis)"
"GSM527881","Prostate tumor PCA0029 transcript","GSM527881","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0029","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527881/GSM527881_YX_Exon1_PCA0029.CEL.gz","43419","Alternative to: GSM526157 (gene-level analysis)"
"GSM527882","Prostate tumor PCA0030 transcript","GSM527882","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0030","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527882/GSM527882_YX_Exon1_PCA0030.CEL.gz","43419","Alternative to: GSM526158 (gene-level analysis)"
"GSM527883","Prostate tumor PCA0031 transcript","GSM527883","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0031","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527883/GSM527883_YX_Exon1_PCA0031.CEL.gz","43419","Alternative to: GSM526159 (gene-level analysis)"
"GSM527884","Prostate tumor PCA0032 transcript","GSM527884","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0032","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527884/GSM527884_YX_Exon1_PCA0032.CEL.gz","43419","Alternative to: GSM526160 (gene-level analysis)"
"GSM527885","Prostate tumor PCA0033 transcript","GSM527885","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0033","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527885/GSM527885_YX_Exon1_PCA0033.CEL.gz","43419","Alternative to: GSM526161 (gene-level analysis)"
"GSM527886","Prostate tumor PCA0034 transcript","GSM527886","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0034","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527886/GSM527886_YX_Exon1_PCA0034.CEL.gz","43419","Alternative to: GSM526162 (gene-level analysis)"
"GSM527887","Prostate tumor PCA0035 transcript","GSM527887","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0035","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527887/GSM527887_YX_Exon1_PCA0035.CEL.gz","43419","Alternative to: GSM526163 (gene-level analysis)"
"GSM527888","Prostate tumor PCA0036 transcript","GSM527888","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0036","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527888/GSM527888_YX_Exon1_PCA0036.CEL.gz","43419","Alternative to: GSM526164 (gene-level analysis)"
"GSM527889","Prostate tumor PCA0037 transcript","GSM527889","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0037","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527889/GSM527889_YX_Exon1_PCA0037.CEL.gz","43419","Alternative to: GSM526165 (gene-level analysis)"
"GSM527890","Prostate tumor PCA0038 transcript","GSM527890","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0038","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527890/GSM527890_YX_PCA0038_HuEx_1.CEL.gz","43419","Alternative to: GSM526166 (gene-level analysis)"
"GSM527891","Prostate tumor PCA0040 transcript","GSM527891","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0040","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527891/GSM527891_YX_Exon1_PCA0040.CEL.gz","43419","Alternative to: GSM526167 (gene-level analysis)"
"GSM527892","Prostate tumor PCA0050 transcript","GSM527892","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0050","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527892/GSM527892_YX_Exon1_PCA0050.CEL.gz","43419","Alternative to: GSM526168 (gene-level analysis)"
"GSM527893","Prostate tumor PCA0052 transcript","GSM527893","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0052","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527893/GSM527893_YX_Exon1_PCA0052.CEL.gz","43419","Alternative to: GSM526169 (gene-level analysis)"
"GSM527894","Prostate tumor PCA0054 transcript","GSM527894","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0054","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527894/GSM527894_YX_Exon1_PCA0054.CEL.gz","43419","Alternative to: GSM526170 (gene-level analysis)"
"GSM527895","Prostate tumor PCA0056 transcript","GSM527895","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0056","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527895/GSM527895_YX_Exon1_PCA0056.CEL.gz","43419","Alternative to: GSM526171 (gene-level analysis)"
"GSM527896","Prostate tumor PCA0057 transcript","GSM527896","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0057","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527896/GSM527896_YX_Exon1_PCA0057.CEL.gz","43419","Alternative to: GSM526172 (gene-level analysis)"
"GSM527897","Prostate tumor PCA0058 transcript","GSM527897","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0058","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527897/GSM527897_YX_PCA0058_HuEx_1.CEL.gz","43419","Alternative to: GSM526173 (gene-level analysis)"
"GSM527898","Prostate tumor PCA0062 transcript","GSM527898","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0062","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527898/GSM527898_YX_Exon1_PCA0062.CEL.gz","43419","Alternative to: GSM526174 (gene-level analysis)"
"GSM527899","Prostate tumor PCA0063 transcript","GSM527899","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0063","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527899/GSM527899_YX_Exon1_PCA0063.CEL.gz","43419","Alternative to: GSM526175 (gene-level analysis)"
"GSM527900","Prostate tumor PCA0064 transcript","GSM527900","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0064","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527900/GSM527900_YX_Exon1_PCA0064.CEL.gz","43419","Alternative to: GSM526176 (gene-level analysis)"
"GSM527901","Prostate tumor PCA0065 transcript","GSM527901","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0065","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527901/GSM527901_YX_Exon1_PCA0065.CEL.gz","43419","Alternative to: GSM526177 (gene-level analysis)"
"GSM527902","Prostate tumor PCA0066 transcript","GSM527902","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0066","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527902/GSM527902_YX_Exon1_PCA0066.CEL.gz","43419","Alternative to: GSM526178 (gene-level analysis)"
"GSM527903","Prostate tumor PCA0068 transcript","GSM527903","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0068","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527903/GSM527903_YX_Exon1_PCA0068.CEL.gz","43419","Alternative to: GSM526179 (gene-level analysis)"
"GSM527904","Prostate tumor PCA0073 transcript","GSM527904","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0073","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T3A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527904/GSM527904_YX_Exon1_PCA0073.CEL.gz","43419","Alternative to: GSM526180 (gene-level analysis)"
"GSM527905","Prostate tumor PCA0074 transcript","GSM527905","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0074","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527905/GSM527905_YX_Exon1_PCA0074.CEL.gz","43419","Alternative to: GSM526181 (gene-level analysis)"
"GSM527906","Prostate tumor PCA0075 transcript","GSM527906","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0075","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527906/GSM527906_YX_Exon1_PCA0075.CEL.gz","43419","Alternative to: GSM526182 (gene-level analysis)"
"GSM527907","Prostate tumor PCA0077 transcript","GSM527907","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0077","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527907/GSM527907_YX_Exon1_PCA0077.CEL.gz","43419","Alternative to: GSM526183 (gene-level analysis)"
"GSM527908","Prostate tumor PCA0080 transcript","GSM527908","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0080","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527908/GSM527908_YX_Exon1_PCA0080.CEL.gz","43419","Alternative to: GSM526184 (gene-level analysis)"
"GSM527909","Prostate tumor PCA0081 transcript","GSM527909","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0081","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527909/GSM527909_YX_Exon1_PCA0081.CEL.gz","43419","Alternative to: GSM526185 (gene-level analysis)"
"GSM527910","Prostate tumor PCA0082 transcript","GSM527910","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0082","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527910/GSM527910_YX_Exon1_PCA0082.CEL.gz","43419","Alternative to: GSM526186 (gene-level analysis)"
"GSM527911","Prostate tumor PCA0083 transcript","GSM527911","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0083","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T3","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527911/GSM527911_YX_Exon1_PCA0083.CEL.gz","43419","Alternative to: GSM526187 (gene-level analysis)"
"GSM527912","Prostate tumor PCA0084 transcript","GSM527912","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0084","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527912/GSM527912_YX_PCA0084_HuEx_1.CEL.gz","43419","Alternative to: GSM526188 (gene-level analysis)"
"GSM527913","Prostate tumor PCA0086 transcript","GSM527913","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0086","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527913/GSM527913_YX_Exon1_PCA0086.CEL.gz","43419","Alternative to: GSM526189 (gene-level analysis)"
"GSM527914","Prostate tumor PCA0087 transcript","GSM527914","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0087","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527914/GSM527914_YX_Exon1_PCA0087.CEL.gz","43419","Alternative to: GSM526190 (gene-level analysis)"
"GSM527915","Prostate tumor PCA0089 transcript","GSM527915","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0089","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527915/GSM527915_YX_Exon1_PCA0089.CEL.gz","43419","Alternative to: GSM526191 (gene-level analysis)"
"GSM527916","Prostate tumor PCA0090 transcript","GSM527916","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0090","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527916/GSM527916_YX_Exon1_PCA0090.CEL.gz","43419","Alternative to: GSM526192 (gene-level analysis)"
"GSM527917","Prostate tumor PCA0092 transcript","GSM527917","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0092","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T3A","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527917/GSM527917_YX_Exon1_PCA0092.CEL.gz","43419","Alternative to: GSM526193 (gene-level analysis)"
"GSM527918","Prostate tumor PCA0093 transcript","GSM527918","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0093","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527918/GSM527918_YX_Exon1_PCA0093.CEL.gz","43419","Alternative to: GSM526194 (gene-level analysis)"
"GSM527919","Prostate tumor PCA0094 transcript","GSM527919","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0094","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527919/GSM527919_YX_Exon1_PCA0094.CEL.gz","43419","Alternative to: GSM526195 (gene-level analysis)"
"GSM527920","Prostate tumor PCA0095 transcript","GSM527920","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0095","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527920/GSM527920_YX_Exon1_PCA0095.CEL.gz","43419","Alternative to: GSM526196 (gene-level analysis)"
"GSM527921","Prostate tumor PCA0096 transcript","GSM527921","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0096","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527921/GSM527921_YX_Exon1_PCA0096.CEL.gz","43419","Alternative to: GSM526197 (gene-level analysis)"
"GSM527922","Prostate tumor PCA0097 transcript","GSM527922","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0097","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527922/GSM527922_YX_Exon1_PCA0097.CEL.gz","43419","Alternative to: GSM526198 (gene-level analysis)"
"GSM527923","Prostate tumor PCA0099 transcript","GSM527923","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0099","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527923/GSM527923_YX_Exon1_PCA0099.CEL.gz","43419","Alternative to: GSM526199 (gene-level analysis)"
"GSM527924","Prostate tumor PCA0100 transcript","GSM527924","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0100","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527924/GSM527924_YX_Exon1_PCA0100.CEL.gz","43419","Alternative to: GSM526200 (gene-level analysis)"
"GSM527925","Prostate tumor PCA0101 transcript","GSM527925","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0101","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527925/GSM527925_YX_Exon1_PCA0101.CEL.gz","43419","Alternative to: GSM526201 (gene-level analysis)"
"GSM527926","Prostate tumor PCA0103 transcript","GSM527926","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0103","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527926/GSM527926_YX_Exon1_PCA0103.CEL.gz","43419","Alternative to: GSM526202 (gene-level analysis)"
"GSM527927","Prostate tumor PCA0104 transcript","GSM527927","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0104","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527927/GSM527927_YX_Exon1_PCA0104.CEL.gz","43419","Alternative to: GSM526203 (gene-level analysis)"
"GSM527928","Prostate tumor PCA0105 transcript","GSM527928","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0105","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527928/GSM527928_YX_Exon1_PCA0105.CEL.gz","43419","Alternative to: GSM526204 (gene-level analysis)"
"GSM527929","Prostate tumor PCA0107 transcript","GSM527929","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0107","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527929/GSM527929_YX_Exon1_PCA0107.CEL.gz","43419","Alternative to: GSM526205 (gene-level analysis)"
"GSM527930","Prostate tumor PCA0108 transcript","GSM527930","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0108","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T3A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527930/GSM527930_YX_Exon1_PCA0108.CEL.gz","43419","Alternative to: GSM526206 (gene-level analysis)"
"GSM527931","Prostate tumor PCA0109 transcript","GSM527931","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0109","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527931/GSM527931_YX_Exon1_PCA0109.CEL.gz","43419","Alternative to: GSM526207 (gene-level analysis)"
"GSM527932","Prostate tumor PCA0110 transcript","GSM527932","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0110","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527932/GSM527932_YX_Exon1_PCA0110.CEL.gz","43419","Alternative to: GSM526208 (gene-level analysis)"
"GSM527933","Prostate tumor PCA0111 transcript","GSM527933","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0111","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527933/GSM527933_YX_Exon1_PCA0111.CEL.gz","43419","Alternative to: GSM526209 (gene-level analysis)"
"GSM527934","Prostate tumor PCA0112 transcript","GSM527934","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0112","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T3A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527934/GSM527934_YX_Exon1_PCA0112.CEL.gz","43419","Alternative to: GSM526210 (gene-level analysis)"
"GSM527935","Prostate tumor PCA0113 transcript","GSM527935","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0113","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527935/GSM527935_YX_Exon1_PCA0113.CEL.gz","43419","Alternative to: GSM526211 (gene-level analysis)"
"GSM527936","Prostate tumor PCA0114 transcript","GSM527936","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0114","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527936/GSM527936_YX_Exon1_PCA0114.CEL.gz","43419","Alternative to: GSM526212 (gene-level analysis)"
"GSM527937","Prostate tumor PCA0115 transcript","GSM527937","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0115","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527937/GSM527937_YX_Exon1_PCA0115.CEL.gz","43419","Alternative to: GSM526213 (gene-level analysis)"
"GSM527938","Prostate tumor PCA0117 transcript","GSM527938","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0117","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527938/GSM527938_YX_Exon1_PCA0117.CEL.gz","43419","Alternative to: GSM526214 (gene-level analysis)"
"GSM527939","Prostate tumor PCA0118 transcript","GSM527939","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0118","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527939/GSM527939_YX_Exon1_PCA0118.CEL.gz","43419","Alternative to: GSM526215 (gene-level analysis)"
"GSM527940","Prostate tumor PCA0119 transcript","GSM527940","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0119","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527940/GSM527940_YX_Exon1_PCA0119.CEL.gz","43419","Alternative to: GSM526216 (gene-level analysis)"
"GSM527941","Prostate tumor PCA0120 transcript","GSM527941","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0120","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527941/GSM527941_YX_Exon1_PCA0120.CEL.gz","43419","Alternative to: GSM526217 (gene-level analysis)"
"GSM527942","Prostate tumor PCA0122 transcript","GSM527942","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0122","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527942/GSM527942_YX_Exon1_PCA0122.CEL.gz","43419","Alternative to: GSM526218 (gene-level analysis)"
"GSM527943","Prostate tumor PCA0123 transcript","GSM527943","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0123","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527943/GSM527943_YX_Exon1_PCA0123.CEL.gz","43419","Alternative to: GSM526219 (gene-level analysis)"
"GSM527944","Prostate tumor PCA0124 transcript","GSM527944","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0124","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527944/GSM527944_YX_Exon1_PCA0124.CEL.gz","43419","Alternative to: GSM526220 (gene-level analysis)"
"GSM527945","Prostate tumor PCA0125 transcript","GSM527945","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0125","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527945/GSM527945_YX_Exon1_PCA0125.CEL.gz","43419","Alternative to: GSM526221 (gene-level analysis)"
"GSM527946","Prostate tumor PCA0126 transcript","GSM527946","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0126","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527946/GSM527946_YX_Exon1_PCA0126.CEL.gz","43419","Alternative to: GSM526222 (gene-level analysis)"
"GSM527947","Prostate tumor PCA0127 transcript","GSM527947","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0127","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527947/GSM527947_YX_Exon1_PCA0127.CEL.gz","43419","Alternative to: GSM526223 (gene-level analysis)"
"GSM527948","Prostate tumor PCA0128 transcript","GSM527948","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0128","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527948/GSM527948_YX_Exon1_PCA0128.CEL.gz","43419","Alternative to: GSM526224 (gene-level analysis)"
"GSM527949","Prostate tumor PCA0129 transcript","GSM527949","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0129","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527949/GSM527949_YX_Exon1_PCA0129.CEL.gz","43419","Alternative to: GSM526225 (gene-level analysis)"
"GSM527950","Prostate tumor PCA0130 transcript","GSM527950","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0130","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527950/GSM527950_YX_Exon1_PCA0130.CEL.gz","43419","Alternative to: GSM526226 (gene-level analysis)"
"GSM527951","Prostate tumor PCA0132 transcript","GSM527951","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0132","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527951/GSM527951_YX_Exon1_PCA0132.CEL.gz","43419","Alternative to: GSM526227 (gene-level analysis)"
"GSM527952","Prostate tumor PCA0133 transcript","GSM527952","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0133","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527952/GSM527952_YX_Exon1_PCA0133.CEL.gz","43419","Alternative to: GSM526228 (gene-level analysis)"
"GSM527953","Prostate tumor PCA0134 transcript","GSM527953","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0134","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527953/GSM527953_YX_Exon1_PCA0134.CEL.gz","43419","Alternative to: GSM526229 (gene-level analysis)"
"GSM527954","Prostate tumor PCA0135 transcript","GSM527954","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0135","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527954/GSM527954_YX_Exon1_PCA0135.CEL.gz","43419","Alternative to: GSM526230 (gene-level analysis)"
"GSM527955","Prostate tumor PCA0136 transcript","GSM527955","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0136","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527955/GSM527955_YX_Exon1_PCA0136.CEL.gz","43419","Alternative to: GSM526231 (gene-level analysis)"
"GSM527956","Prostate tumor PCA0141 transcript","GSM527956","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0141","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527956/GSM527956_YX_Exon1_PCA0141.CEL.gz","43419","Alternative to: GSM526232 (gene-level analysis)"
"GSM527957","Prostate tumor PCA0144 transcript","GSM527957","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0144","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527957/GSM527957_YX_Exon1_PCA0144.CEL.gz","43419","Alternative to: GSM526233 (gene-level analysis)"
"GSM527958","Prostate tumor PCA0145 transcript","GSM527958","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0145","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527958/GSM527958_YX_Exon1_PCA0145.CEL.gz","43419","Alternative to: GSM526234 (gene-level analysis)"
"GSM527959","Prostate tumor PCA0146 transcript","GSM527959","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0146","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527959/GSM527959_YX_Exon1_PCA0146.CEL.gz","43419","Alternative to: GSM526235 (gene-level analysis)"
"GSM527960","Prostate tumor PCA0147 transcript","GSM527960","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0147","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527960/GSM527960_YX_Exon1_PCA0147.CEL.gz","43419","Alternative to: GSM526236 (gene-level analysis)"
"GSM527961","Prostate tumor PCA0149 transcript","GSM527961","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0149","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527961/GSM527961_YX_Exon1_PCA0149.CEL.gz","43419","Alternative to: GSM526237 (gene-level analysis)"
"GSM527962","Prostate tumor PCA0150 transcript","GSM527962","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0150","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527962/GSM527962_YX_PCA0150_HuEx_1.CEL.gz","43419","Alternative to: GSM526238 (gene-level analysis)"
"GSM527963","Prostate tumor PCA0151 transcript","GSM527963","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0151","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527963/GSM527963_YX_Exon1_PCA0151.CEL.gz","43419","Alternative to: GSM526239 (gene-level analysis)"
"GSM527965","Prostate tumor PCA0155 transcript","GSM527965","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0155","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527965/GSM527965_YX_Exon1_PCA0155.CEL.gz","43419","Alternative to: GSM526240 (gene-level analysis)"
"GSM527966","Prostate tumor PCA0156 transcript","GSM527966","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0156","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527966/GSM527966_YX_Exon1_PCA0156.CEL.gz","43419","Alternative to: GSM526241 (gene-level analysis)"
"GSM527968","Prostate tumor PCA0157 transcript","GSM527968","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0157","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527968/GSM527968_YX_Exon1_PCA0157.CEL.gz","43419","Alternative to: GSM526242 (gene-level analysis)"
"GSM527970","Prostate tumor PCA0158 transcript","GSM527970","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0158","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527970/GSM527970_YX_Exon1_PCA0158.CEL.gz","43419","Alternative to: GSM526243 (gene-level analysis)"
"GSM527971","Prostate tumor PCA0159 transcript","GSM527971","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0159","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527971/GSM527971_YX_Exon1_PCA0159.CEL.gz","43419","Alternative to: GSM526244 (gene-level analysis)"
"GSM527972","Prostate tumor PCA0160 transcript","GSM527972","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0160","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527972/GSM527972_YX_Exon1_PCA0160.CEL.gz","43419","Alternative to: GSM526245 (gene-level analysis)"
"GSM527973","Prostate tumor PCA0161 transcript","GSM527973","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0161","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527973/GSM527973_YX_Exon1_PCA0161.CEL.gz","43419","Alternative to: GSM526246 (gene-level analysis)"
"GSM527974","Prostate tumor PCA0162 transcript","GSM527974","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0162","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527974/GSM527974_YX_Exon1_PCA0162.CEL.gz","43419","Alternative to: GSM526247 (gene-level analysis)"
"GSM527975","Prostate tumor PCA0163 transcript","GSM527975","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0163","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527975/GSM527975_YX_Exon1_PCA0163.CEL.gz","43419","Alternative to: GSM526248 (gene-level analysis)"
"GSM527977","Prostate tumor PCA0164 transcript","GSM527977","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0164","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527977/GSM527977_YX_Exon1_PCA0164.CEL.gz","43419","Alternative to: GSM526249 (gene-level analysis)"
"GSM527979","Prostate tumor PCA0165 transcript","GSM527979","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0165","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527979/GSM527979_YX_Exon1_PCA0165.CEL.gz","43419","Alternative to: GSM526250 (gene-level analysis)"
"GSM527980","Prostate tumor PCA0167 transcript","GSM527980","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0167","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527980/GSM527980_YX_Exon1_PCA0167.CEL.gz","43419","Alternative to: GSM526251 (gene-level analysis)"
"GSM527982","Prostate tumor PCA0168 transcript","GSM527982","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0168","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527982/GSM527982_YX_Exon1_PCA0168.CEL.gz","43419","Alternative to: GSM526252 (gene-level analysis)"
"GSM527984","Prostate tumor PCA0169 transcript","GSM527984","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0169","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527984/GSM527984_YX_Exon1_PCA0169.CEL.gz","43419","Alternative to: GSM526253 (gene-level analysis)"
"GSM527985","Prostate tumor PCA0170 transcript","GSM527985","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0170","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527985/GSM527985_YX_Exon1_PCA0170.CEL.gz","43419","Alternative to: GSM526254 (gene-level analysis)"
"GSM527986","Prostate tumor PCA0171 transcript","GSM527986","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0171","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527986/GSM527986_YX_Exon1_PCA0171.CEL.gz","43419","Alternative to: GSM526255 (gene-level analysis)"
"GSM527987","Prostate tumor PCA0172 transcript","GSM527987","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0172","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527987/GSM527987_YX_Exon1_PCA0172.CEL.gz","43419","Alternative to: GSM526256 (gene-level analysis)"
"GSM527988","Prostate tumor PCA0173 transcript","GSM527988","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0173","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527988/GSM527988_YX_Exon1_PCA0173.CEL.gz","43419","Alternative to: GSM526257 (gene-level analysis)"
"GSM527989","Prostate tumor PCA0174 transcript","GSM527989","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0174","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527989/GSM527989_YX_Exon1_PCA0174.CEL.gz","43419","Alternative to: GSM526258 (gene-level analysis)"
"GSM527990","Prostate tumor PCA0175 transcript","GSM527990","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0175","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527990/GSM527990_YX_Exon1_PCA0175.CEL.gz","43419","Alternative to: GSM526259 (gene-level analysis)"
"GSM527991","Prostate tumor PCA0176 transcript","GSM527991","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0176","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527991/GSM527991_YX_Exon1_PCA0176.CEL.gz","43419","Alternative to: GSM526260 (gene-level analysis)"
"GSM527992","Prostate tumor PCA0178 transcript","GSM527992","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0178","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527992/GSM527992_YX_Exon1_PCA0178.CEL.gz","43419","Alternative to: GSM526261 (gene-level analysis)"
"GSM527993","Prostate tumor PCA0179 transcript","GSM527993","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0179","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527993/GSM527993_YX_Exon1_PCA0179.CEL.gz","43419","Alternative to: GSM526262 (gene-level analysis)"
"GSM527994","Prostate tumor PCA0180 transcript","GSM527994","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0180","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527994/GSM527994_YX_Exon1_PCA0180.CEL.gz","43419","Alternative to: GSM526263 (gene-level analysis)"
"GSM527995","Prostate tumor PCA0181 transcript","GSM527995","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0181","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527995/GSM527995_YX_Exon1_PCA0181.CEL.gz","43419","Alternative to: GSM526264 (gene-level analysis)"
"GSM527996","Prostate tumor PCA0182 transcript","GSM527996","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0182","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527996/GSM527996_YX_Exon1_PCA0182.CEL.gz","43419","Alternative to: GSM526265 (gene-level analysis)"
"GSM527997","Prostate tumor PCA0184 transcript","GSM527997","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0184","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527997/GSM527997_YX_Exon1_PCA0184.CEL.gz","43419","Alternative to: GSM526266 (gene-level analysis)"
"GSM527998","Prostate tumor PCA0187 transcript","GSM527998","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0187","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527998/GSM527998_YX_Exon1_PCA0187.CEL.gz","43419","Alternative to: GSM526267 (gene-level analysis)"
"GSM527999","Prostate tumor PCA0188 transcript","GSM527999","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0188","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM527nnn/GSM527999/GSM527999_YX_Exon1_PCA0188.CEL.gz","43419","Alternative to: GSM526268 (gene-level analysis)"
"GSM528000","Prostate tumor PCA0189 transcript","GSM528000","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0189","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 8","clint_stage: T2B","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528000/GSM528000_YX_Exon1_PCA0189.CEL.gz","43419","Alternative to: GSM526269 (gene-level analysis)"
"GSM528001","Prostate tumor PCA0190 transcript","GSM528001","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0190","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: NA","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528001/GSM528001_YX_Exon1_PCA0190.CEL.gz","43419","Alternative to: GSM526270 (gene-level analysis)"
"GSM528002","Prostate tumor PCA0193 transcript","GSM528002","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0193","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: T2A","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528002/GSM528002_YX_Exon1_PCA0193.CEL.gz","43419","Alternative to: GSM526271 (gene-level analysis)"
"GSM528003","Prostate tumor PCA0194 transcript","GSM528003","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0194","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 6","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528003/GSM528003_YX_Exon1_PCA0194.CEL.gz","43419","Alternative to: GSM526272 (gene-level analysis)"
"GSM528004","Prostate tumor PCA0199 transcript","GSM528004","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0199","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: T4","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528004/GSM528004_YX_Exon1_PCA0199.CEL.gz","43419","Alternative to: GSM526273 (gene-level analysis)"
"GSM528005","Prostate tumor PCA0200 transcript","GSM528005","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0200","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528005/GSM528005_YX_Exon1_PCA0200.CEL.gz","43419","Alternative to: GSM526274 (gene-level analysis)"
"GSM528006","Prostate tumor PCA0201 transcript","GSM528006","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0201","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528006/GSM528006_YX_Exon1_PCA0201.CEL.gz","43419","Alternative to: GSM526275 (gene-level analysis)"
"GSM528007","Prostate tumor PCA0206 transcript","GSM528007","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0206","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528007/GSM528007_YX_Exon1_PCA0206.CEL.gz","43419","Alternative to: GSM526276 (gene-level analysis)"
"GSM528008","Prostate tumor PCA0207 transcript","GSM528008","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0207","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528008/GSM528008_YX_Exon1_PCA0207.CEL.gz","43419","Alternative to: GSM526277 (gene-level analysis)"
"GSM528009","Prostate tumor PCA0208 transcript","GSM528009","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0208","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528009/GSM528009_YX_Exon1_PCA0208.CEL.gz","43419","Alternative to: GSM526278 (gene-level analysis)"
"GSM528010","Prostate tumor PCA0209 transcript","GSM528010","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0209","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 8","clint_stage: T2C","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528010/GSM528010_YX_PCA0209_HuEx_1.CEL.gz","43419","Alternative to: GSM526279 (gene-level analysis)"
"GSM528011","Prostate tumor PCA0210 transcript","GSM528011","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0210","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528011/GSM528011_YX_PCA0210_HuEx_1.CEL.gz","43419","Alternative to: GSM526280 (gene-level analysis)"
"GSM528012","Prostate tumor PCA0211 transcript","GSM528012","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0211","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528012/GSM528012_YX_Exon1_PCA0211.CEL.gz","43419","Alternative to: GSM526281 (gene-level analysis)"
"GSM528013","Prostate tumor PCA0213 transcript","GSM528013","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0213","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: NA","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528013/GSM528013_YX_Exon1_PCA0213.CEL.gz","43419","Alternative to: GSM526282 (gene-level analysis)"
"GSM528014","Prostate tumor PCA0215 transcript","GSM528014","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0215","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 8","clint_stage: T3","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528014/GSM528014_YX_PCA0215_HuEx_1.CEL.gz","43419","Alternative to: GSM526283 (gene-level analysis)"
"GSM528015","Cell line DU145 transcript","GSM528015","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: DU145","tissue: Prostate","cell line: DU145","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528015/GSM528015_YX_Exon1_DU145.CEL.gz","43419","Alternative to: GSM526284 (gene-level analysis)"
"GSM528016","Cell line LNCaP transcript","GSM528016","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: LNCaP","tissue: Prostate","cell line: LNCaP","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528016/GSM528016_YX_Exon1_LNCaP.CEL.gz","43419","Alternative to: GSM526285 (gene-level analysis)"
"GSM528017","Xenograft LNCaP104R transcript","GSM528017","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate xenograft","Homo sapiens","sample id: LNCaP104R","tissue: Prostate","cell type: Xenograft LNCaP104R","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528017/GSM528017_YX_Exon1_LNCaP104R.CEL.gz","43419","Alternative to: GSM526286 (gene-level analysis)"
"GSM528018","Xenograft LNCaP104S transcript","GSM528018","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate xenograft","Homo sapiens","sample id: LNCaP104S","tissue: Prostate","cell type: Xenograft LNCaP104S","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528018/GSM528018_YX_Exon1_LNCaP104S.CEL.gz","43419","Alternative to: GSM526287 (gene-level analysis)"
"GSM528019","Cell line PC3 transcript","GSM528019","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: PC3","tissue: Prostate","cell line: PC3","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528019/GSM528019_YX_Exon1_PC3.CEL.gz","43419","Alternative to: GSM526288 (gene-level analysis)"
"GSM528020","Cell line Vcap transcript","GSM528020","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: Vcap","tissue: Prostate","cell line: Vcap","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528020/GSM528020_YX_Exon1_Vcap.CEL.gz","43419","Alternative to: GSM526289 (gene-level analysis)"
"GSM528021","Prostate normal PAN0095 transcript","GSM528021","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0095","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528021/GSM528021_YX_Exon1_PAN0095.CEL.gz","43419","Alternative to: GSM526290 (gene-level analysis)"
"GSM528022","Prostate normal PAN0107 transcript","GSM528022","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0107","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528022/GSM528022_YX_Exon1_PAN0107.CEL.gz","43419","Alternative to: GSM526291 (gene-level analysis)"
"GSM528023","Prostate normal PAN0109 transcript","GSM528023","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0109","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528023/GSM528023_YX_Exon1_PAN0109.CEL.gz","43419","Alternative to: GSM526292 (gene-level analysis)"
"GSM528024","Prostate normal PAN0110 transcript","GSM528024","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0110","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528024/GSM528024_YX_Exon1_PAN0110.CEL.gz","43419","Alternative to: GSM526293 (gene-level analysis)"
"GSM528025","Prostate normal PAN0112 transcript","GSM528025","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0112","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528025/GSM528025_YX_Exon1_PAN0112.CEL.gz","43419","Alternative to: GSM526294 (gene-level analysis)"
"GSM528026","Prostate normal PAN0113 transcript","GSM528026","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0113","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528026/GSM528026_YX_Exon1_PAN0113.CEL.gz","43419","Alternative to: GSM526295 (gene-level analysis)"
"GSM528027","Prostate normal PAN0114 transcript","GSM528027","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0114","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528027/GSM528027_YX_Exon1_PAN0114.CEL.gz","43419","Alternative to: GSM526296 (gene-level analysis)"
"GSM528028","Prostate normal PAN0115 transcript","GSM528028","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0115","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528028/GSM528028_YX_Exon1_PAN0115.CEL.gz","43419","Alternative to: GSM526297 (gene-level analysis)"
"GSM528029","Prostate normal PAN0117 transcript","GSM528029","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0117","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528029/GSM528029_YX_Exon1_PAN0117.CEL.gz","43419","Alternative to: GSM526298 (gene-level analysis)"
"GSM528030","Prostate normal PAN0120 transcript","GSM528030","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0120","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528030/GSM528030_YX_Exon1_PAN0120.CEL.gz","43419","Alternative to: GSM526299 (gene-level analysis)"
"GSM528031","Prostate normal PAN0122 transcript","GSM528031","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0122","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528031/GSM528031_YX_Exon1_PAN0122.CEL.gz","43419","Alternative to: GSM526300 (gene-level analysis)"
"GSM528032","Prostate normal PAN0125 transcript","GSM528032","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0125","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528032/GSM528032_YX_Exon1_PAN0125.CEL.gz","43419","Alternative to: GSM526301 (gene-level analysis)"
"GSM528033","Prostate normal PAN0127 transcript","GSM528033","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0127","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528033/GSM528033_YX_Exon1_PAN0127.CEL.gz","43419","Alternative to: GSM526302 (gene-level analysis)"
"GSM528034","Prostate normal PAN0128 transcript","GSM528034","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0128","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528034/GSM528034_YX_Exon1_PAN0128.CEL.gz","43419","Alternative to: GSM526303 (gene-level analysis)"
"GSM528035","Prostate normal PAN0129 transcript","GSM528035","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0129","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528035/GSM528035_YX_Exon1_PAN0129.CEL.gz","43419","Alternative to: GSM526304 (gene-level analysis)"
"GSM528036","Prostate normal PAN0134 transcript","GSM528036","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0134","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528036/GSM528036_YX_Exon1_PAN0134.CEL.gz","43419","Alternative to: GSM526305 (gene-level analysis)"
"GSM528037","Prostate normal PAN0135 transcript","GSM528037","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0135","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528037/GSM528037_YX_Exon1_PAN0135.CEL.gz","43419","Alternative to: GSM526306 (gene-level analysis)"
"GSM528038","Prostate normal PAN0136 transcript","GSM528038","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0136","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528038/GSM528038_YX_Exon1_PAN0136.CEL.gz","43419","Alternative to: GSM526307 (gene-level analysis)"
"GSM528039","Prostate normal PAN0144 transcript","GSM528039","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0144","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528039/GSM528039_YX_Exon1_PAN0144.CEL.gz","43419","Alternative to: GSM526308 (gene-level analysis)"
"GSM528040","Prostate normal PAN0147 transcript","GSM528040","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0147","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528040/GSM528040_YX_Exon1_PAN0147.CEL.gz","43419","Alternative to: GSM526309 (gene-level analysis)"
"GSM528041","Prostate normal PAN0151 transcript","GSM528041","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0151","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528041/GSM528041_YX_Exon1_PAN0151.CEL.gz","43419","Alternative to: GSM526310 (gene-level analysis)"
"GSM528042","Prostate normal PAN0157 transcript","GSM528042","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0157","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528042/GSM528042_YX_Exon1_PAN0157.CEL.gz","43419","Alternative to: GSM526311 (gene-level analysis)"
"GSM528043","Prostate normal PAN0162 transcript","GSM528043","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0162","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528043/GSM528043_YX_Exon1_PAN0162.CEL.gz","43419","Alternative to: GSM526312 (gene-level analysis)"
"GSM528044","Prostate normal PAN0164 transcript","GSM528044","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0164","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528044/GSM528044_YX_Exon1_PAN0164.CEL.gz","43419","Alternative to: GSM526313 (gene-level analysis)"
"GSM528045","Prostate normal PAN0167 transcript","GSM528045","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0167","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528045/GSM528045_YX_Exon1_PAN0167.CEL.gz","43419","Alternative to: GSM526314 (gene-level analysis)"
"GSM528046","Prostate normal PAN0169 transcript","GSM528046","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0169","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528046/GSM528046_YX_Exon1_PAN0169.CEL.gz","43419","Alternative to: GSM526315 (gene-level analysis)"
"GSM528047","Prostate normal PAN0171 transcript","GSM528047","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0171","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528047/GSM528047_YX_Exon1_PAN0171.CEL.gz","43419","Alternative to: GSM526316 (gene-level analysis)"
"GSM528048","Prostate normal PAN0172 transcript","GSM528048","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0172","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528048/GSM528048_YX_Exon1_PAN0172.CEL.gz","43419","Alternative to: GSM526317 (gene-level analysis)"
"GSM528049","Prostate normal PAN0174 transcript","GSM528049","Public on Jun 24 2010","Mar 29 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0174","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL10264","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM528nnn/GSM528049/GSM528049_YX_Exon1_PAN0174.CEL.gz","43419","Alternative to: GSM526318 (gene-level analysis)"
